Korean J Anesthesiol.  2016 Dec;69(6):627-631. 10.4097/kjae.2016.69.6.627.

Dexmedetomidine for sedation in pediatric patients who received more than 20 sessions of radiation therapy: two cases report

• Kim SK
• Song MH
• Lee IJ
• Lee JH
• Choi IC

• KMID: 2360480
• DOI: http://doi.org/10.4097/kjae.2016.69.6.627

Abstract

Dexmedetomidine is a highly selective α2-adrenoceptor agonist that demonstrates anxiolytic and analgesic properties without inducing respiratory compromise, which makes it a suitable agent for procedural sedation and imaging studies. In our current case reports, intravenous dexmedetomidine infusion was used to provide sedation to 2 pediatric patients over more than 20 sessions of radiation therapy. On both occasions, dexmedetomidine provided adequate sedation without respiratory depression. However, the required dosage increased with repeated radiation therapy sessions.

Keyword

Dexmedetomidine; Pediatrics; Radiotherapy

MeSH Terms

Dexmedetomidine*
Humans
Pediatrics
Radiotherapy
Respiratory Insufficiency
Dexmedetomidine